<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Tetralogy of Fallot (TOF): Pathophysiology, clinical features, and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Tetralogy of Fallot (TOF): Pathophysiology, clinical features, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Tetralogy of Fallot (TOF): Pathophysiology, clinical features, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas Doyle, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ann Kavanaugh-McHugh, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heidi M Connolly, MD, FACC, FASE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John K Triedman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 04, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2053872"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Tetralogy of Fallot (TOF) includes the following major features (<a class="graphic graphic_figure graphicRef82493" href="/z/d/graphic/82493.html" rel="external">figure 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Right ventricular outflow tract (RVOT) obstruction</p><p class="bulletIndent1"><span class="glyph">●</span>Malalignment ventricular septal defect (VSD)</p><p class="bulletIndent1"><span class="glyph">●</span>Overriding aorta</p><p class="bulletIndent1"><span class="glyph">●</span>Concentric RV hypertrophy</p><p></p><p>The pathophysiology, clinical features, and diagnosis of TOF will be reviewed here. Other related topics include:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/141526.html" rel="external">"Tetralogy of Fallot (TOF): Long-term complications and follow-up after repair"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/88284.html" rel="external">"Tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries (TOF/PA/MAPCAs)"</a>.)</p><p></p><p class="headingAnchor" id="H2053878"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The prevalence of TOF in the United States is approximately 4 to 5 per 10,000 live births [<a href="#rid1">1,2</a>]. This defect accounts for approximately 7 to 10 percent of cases of congenital heart disease and is one of the most common congenital heart lesions requiring intervention in the first year of life [<a href="#rid3">3</a>]. TOF occurs equally in males and females [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H2053884"><span class="h1">ANATOMY</span><span class="headingEndMark"> — </span>The exact embryologic abnormality that accounts for TOF is unknown. What is recognized is that during development, there is anterior and cephalad deviation of the infundibular septum. This results in a malaligned ventricular septal defect (VSD), with the aortic root overriding the defect and leading to subsequent right ventricular outflow tract (RVOT) obstruction (<a class="graphic graphic_figure graphicRef82493" href="/z/d/graphic/82493.html" rel="external">figure 1</a>). The ensuing RV hypertrophy is thought to be a response to the large VSD and RVOT obstruction, with resultant systemic RV systolic pressure.</p><p class="headingAnchor" id="H2053890"><span class="h2">Ventricular septal defect</span><span class="headingEndMark"> — </span>The VSD in TOF is most commonly a single large, malaligned subaortic defect located in the perimembranous region of the septum (<a class="graphic graphic_diagnosticimage graphicRef52641" href="/z/d/graphic/52641.html" rel="external">image 1</a>). The VSD can extend into the muscular septum. There are rarely other muscular VSDs. (See  <a class="medical medical_review" href="/z/d/html/5787.html" rel="external">"Isolated ventricular septal defects (VSDs) in infants and children: Anatomy, clinical features, and diagnosis"</a>.)</p><p class="headingAnchor" id="H2053896"><span class="h2">Right ventricular outflow tract obstruction</span><span class="headingEndMark"> — </span>The RVOT obstruction is often at multiple levels (<a class="graphic graphic_diagnosticimage graphicRef57537" href="/z/d/graphic/57537.html" rel="external">image 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Anterior and cephalad deviation of the infundibular septum results in subvalvar obstruction</p><p class="bulletIndent1"><span class="glyph">●</span>Hypertrophy of muscular bands in this region can further accentuate subvalvar obstruction</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary valve annulus is usually hypoplastic, although, in some instances, it is of normal size</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary valve itself is frequently bicuspid and stenotic</p><p></p><p>In addition, it is not uncommon to identify an area of supravalvar narrowing in the main pulmonary artery at the sinotubular ridge. There may also be further obstruction at the branch pulmonary arteries. These may be diffusely hypoplastic or have focal areas of stenosis, most commonly at the proximal branch pulmonary arteries. The proximal left pulmonary artery near the site of ductal insertion is a frequent location for stenosis (<a class="graphic graphic_diagnosticimage graphicRef64416 graphicRef78255" href="/z/d/graphic/64416.html" rel="external">image 3A-B</a>).</p><p class="headingAnchor" id="H2053902"><span class="h2">Overriding aorta</span><span class="headingEndMark"> — </span>Overriding aorta is a congenital anomaly in which the aorta is displaced to the right over the VSD rather than the left ventricle. This results in blood flow from both ventricles entering into the aorta.</p><p>The degree of aortic override of the VSD can vary widely and is one of the major factors used by some groups to differentiate between TOF and double-outlet RV. If one defines double-outlet RV as the absence of aortic/mitral valve fibrous continuity, then the degree of override is not relevant to diagnosis. If, however, one defines double-outlet RV as a condition with greater than 50 percent aortic override, then, by definition, the degree of aortic override in TOF is limited.</p><p class="headingAnchor" id="H2053908"><span class="h2">Associated cardiac features</span><span class="headingEndMark"> — </span>There are a number of frequently associated anatomic features that are important to look for when evaluating a patient with TOF since they affect therapy. Associated cardiac anomalies occur in approximately 40 percent of patients with TOF [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Approximately 25 percent of patients have a right aortic arch. This is particularly important to identify if one is contemplating a palliative shunt.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormalities of the coronary arteries, such as the left anterior descending arising from the right coronary artery, are seen in approximately 10 percent of patients [<a href="#rid5">5,6</a>]. These are important to identify prior to complete repair since the course of the artery may run directly across the RVOT; inadvertent transection could have catastrophic consequences.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Occasionally, patients have significant aorticopulmonary collateral vessels that may require attention prior to or at the time of surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A patent ductus arteriosus, multiple ventricular defects, and complete atrioventricular septal defects may be present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infrequently, aortic valve regurgitation is present due to aortic cusp prolapse.</p><p></p><p class="headingAnchor" id="H2053914"><span class="h1">GENETIC FACTORS</span><span class="headingEndMark"> — </span>Although TOF may present as part of a known syndrome, this lesion typically occurs sporadically without other anomalies.</p><p>Surveys of patients with nonsyndromic TOF have reported the following genetic abnormalities:</p><p class="bulletIndent1"><span class="glyph">●</span>In one study of 114 patients with nonsyndromic TOF, 4 percent of patients had mutations in transcription factor <em>NKX2-5</em>, which appears to have a role in cardiac development [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In genome-wide surveys of patients with nonsyndromic TOF and their parents, de novo copy number variants were estimated to be present in approximately 10 percent of sporadic cases of TOF, compared with less than 0.1 percent in controls, at several chromosomal locations [<a href="#rid8">8</a>]. Several reports have associated TOF with mutations in <em>TBX1</em>, <em>ZFPM2</em>, and <em>GATA5</em> [<a href="#rid9">9-12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>MTHFR</em> polymorphism has also been associated with an increased risk of development of TOF [<a href="#rid13">13</a>].</p><p></p><p>Further investigation is required to determine the role of these mutations and polymorphisms in the evolution of TOF.</p><p>Approximately 15 percent of patients with TOF present with associated syndromes [<a href="#rid9">9,14-20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Down syndrome (trisomy 21). (See  <a class="medical medical_review" href="/z/d/html/2917.html" rel="external">"Down syndrome: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alagille syndrome (mutations in <em>JAG1</em>). TOF as the sole manifestation of <em>JAG1</em> mutations without other evidence of Alagille syndrome has also been reported [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/z/d/html/3584.html" rel="external">"Inherited disorders associated with conjugated hyperbilirubinemia", section on 'Alagille syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>DiGeorge and velocardiofacial syndromes (deletion on chromosome 22q11). There may be susceptibility genes for TOF within the latter region of chromosome 22q11 in children without extracardiac anomalies [<a href="#rid19">19,22,23</a>], and 22q11.2 deletion syndrome is unrecognized in many adult patients with TOF [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/83396.html" rel="external">"DiGeorge (22q11.2 deletion) syndrome: Clinical features and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H2053920"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>The physiologic consequences of TOF are largely dependent upon the degree of right ventricular (RV) outflow obstruction. Since the ventricular septal defect (VSD) is typically large and unrestrictive, the pressure in the RV reflects that of the left ventricle. As a result, the direction of blood flow across the VSD will be determined by the path of least resistance for blood flow, not by the size of the VSD. If the resistance to blood flow across the obstructed RV outflow tract (RVOT) is less than the resistance to flow out of the aorta into the systemic circulation, blood will naturally shunt from the left ventricle to the RV and into the pulmonary bed. In this situation, there is predominately a left-to-right shunt, and the patient will be acyanotic.</p><p>As the degree of RV outflow obstruction increases, the resistance to blood flow into the pulmonary bed also increases. If the RV obstruction exceeds systemic resistance, it becomes easier for blood to cross the VSD from the RV into the left ventricle and go out the aorta. This right-to-left shunt across the VSD results in a large volume of desaturated blood entering the systemic circulation, causing cyanosis (<a class="graphic graphic_figure graphicRef82493" href="/z/d/graphic/82493.html" rel="external">figure 1</a>). In patients with unrepaired TOF, chronic cyanosis can result in erythrocythemia.</p><p>One of the physiologic characteristics of TOF is that the RVOT obstruction can fluctuate. An individual with minimal cyanosis can develop a dynamic increase in RVOT obstruction with a subsequent increase in right-to-left shunt and the development of cyanosis. In the most dramatic situation, there can be near occlusion of the RVOT with profound cyanosis. These episodes are often referred to as "tet spells" or "hypercyanotic spells." (See <a class="local">'Tet spells'</a> below.)</p><p class="headingAnchor" id="H2053926"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H3792923580"><span class="h2">Presentation</span><span class="headingEndMark"> — </span>With advances in obstetric ultrasound screening, many infants with TOF are diagnosed prenatally. (See <a class="local">'Prenatal diagnosis'</a> below.)</p><p>For patients not diagnosed prenatally, postnatal presentation depends upon the degree of right ventricular outflow tract (RVOT) obstruction:</p><p class="bulletIndent1"><span class="glyph">●</span>Infants with severe RVOT obstruction and inadequate pulmonary flow typically present in the immediate newborn period with profound cyanosis and require intervention.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infants with mild to moderate RVOT obstruction and balanced pulmonary and systemic flow may be asymptomatic initially. They may be referred for cardiology evaluation and diagnosed during evaluation of a murmur noted in the nursery or in the course of well-child care. These children are referred to as "pink tets." Importantly, the degree of RVOT obstruction is progressive over time. An initially asymptomatic and acyanotic child may gradually develop increasing cyanosis and/or present with hypercyanotic ("tet") spells when the gradually increasing RVOT obstruction is abruptly and dynamically increased during periods of excitement, agitation, or hypovolemia. (See <a class="local">'Tet spells'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infants with minimal obstruction are also asymptomatic initially. They may develop symptoms of pulmonary overcirculation and heart failure in the first four to six weeks after birth as the initially elevated perinatal pulmonary vascular resistance falls to normal.</p><p></p><p>In addition, some affected newborns will be detected by an evaluation prompted by a failed pulse oximetry screening test. (See  <a class="medical medical_review" href="/z/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p>In general, the earlier the onset of cyanosis, the more likely that severe RVOT obstruction is present.</p><p>In the contemporary era in the United States, most children are diagnosed in infancy; however, this is not true in regions of the world where access to health care is more limited. Rarely, and most often in the course of relocation from those regions, older children with unrepaired TOF may present, usually with some degree of baseline cyanosis, often limiting their own activities to prevent hypercyanotic episodes.</p><p class="headingAnchor" id="H2769872344"><span class="h2">Tet spells</span><span class="headingEndMark"> — </span>Patients with unrepaired TOF are at risk for episodic hypercyanotic ("tet") spells in which there can be transient near occlusion of the RVOT with profound cyanosis. The exact etiology of these episodes is unclear, although there have been a number of proposed mechanisms, including increased infundibular contractility, peripheral vasodilatation, hyperventilation, and stimulation of RV mechanoreceptors [<a href="#rid25">25</a>].</p><p>Tet spells typically arise when the infant becomes agitated or upset. They may also occur in the setting of pain, fever, anemia, and hypovolemia, as well as after a bowel movement or feeding (or, in older children with uncorrected TOF, after vigorous exercise) [<a href="#rid26">26</a>]. They may occur more commonly in the morning and after feeding, though they can arise at any time [<a href="#rid5">5</a>].</p><p>Tet spells are characterized by hyperpnea (rapid and deep respirations), irritability, inconsolability, and progressively severe cyanosis. An older child experiencing a tet spell will typically squat to recover. Examination during the acute episode may reveal decreased intensity of the heart murmur. Though some episodes may resolve spontaneously, prolonged spells can progress to loss of consciousness and cardiac arrest. Prompt intervention is essential for the acute episode and infants, and children presenting with hypercyanotic episodes should be referred for surgical intervention to prevent potentially life-threatening recurrences. Acute management of tet spells is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome", section on 'Tet spells'</a>.)</p><p class="headingAnchor" id="H2053932"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>On inspection, individuals with TOF are usually comfortable and in no distress. However, during hypercyanotic (tet) spells, they will become hyperpneic and infants will often become agitated. If cyanosis is present, it is most easily seen in the nail beds and lips.</p><p>On palpation, one may appreciate a prominent RV impulse and, occasionally, a systolic thrill. Hepatomegaly is uncommon. Peripheral pulses are usually normal, although the presence of prominent pulses may suggest the existence of a significant patent ductus arteriosus or aorticopulmonary collaterals.</p><p class="headingAnchor" id="H2053938"><span class="h2">Cardiac auscultation</span><span class="headingEndMark"> — </span>On auscultation, the first heart sound is normal and the second heart sound is most commonly single because the pulmonic component is rarely audible. Third and fourth heart sounds are uncommon. An early systolic click along the left sternal border may be heard, which is thought to be due to flow into the dilated ascending aorta. (See  <a class="medical medical_review" href="/z/d/html/103723.html" rel="external">"Approach to the infant or child with a cardiac murmur", section on 'Heart sounds'</a>.)</p><p class="headingAnchor" id="H2053944"><span class="h3">Murmur</span><span class="headingEndMark"> — </span>The murmur in TOF is due primarily to the RV outflow obstruction, not the ventricular septal defect (VSD). The murmur is typically a systolic, crescendo-decrescendo murmur with a harsh ejection quality; it is appreciated best along the left mid- to upper sternal border with radiation posteriorly. It can, however, have a more regurgitant quality that can be easily mistaken for a VSD. (See  <a class="medical medical_review" href="/z/d/html/103723.html" rel="external">"Approach to the infant or child with a cardiac murmur"</a>.)</p><p>The murmur is due both to the degree of obstruction and to the amount of flow across the obstruction. In TOF, unlike isolated valvar pulmonary stenosis, the amount of flow across the RVOT will decrease as the obstruction increases, due to the shunting of blood right-to-left across the VSD. Thus, as the obstruction increases, the murmur will become softer. During severe hypercyanotic ("tet") spells, the murmur may actually disappear due to the markedly diminished flow across the obstruction. (See  <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome", section on 'Tet spells'</a>.)</p><p class="headingAnchor" id="H3248446146"><span class="h1">PRENATAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Improvements in prenatal screening and fetal echocardiography have led to an increase in rates of prenatal diagnosis of TOF [<a href="#rid27">27-29</a>]. Fetal diagnosis allows for advanced planning for delivery and perinatal management, which is particularly important if there is evidence of severe right ventricular outflow tract (RVOT) obstruction necessitating prostaglandin therapy to maintain ductal patency. (See  <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome", section on 'Neonates with severe RVOT obstruction'</a>.)</p><p>Prenatal risk factors predicting the need for perinatal intervention continue to be identified and include the direction of ductal shunting, pulmonary valve Z scores, pulmonary velocity, pulmonary valve/aortic valve diameter ratios, and subpulmonary/descending aorta ratios [<a href="#rid30">30-35</a>]. </p><p>The approach to screening, evaluation, and pregnancy management of suspected fetal cardiac abnormalities is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6755.html" rel="external">"Congenital heart disease: Prenatal screening, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H2053950"><span class="h1">POSTNATAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of TOF is generally made by echocardiography. Other tests that are often performed during the evaluation of TOF include electrocardiogram (ECG) and chest radiography. Findings from the ECG and chest radiograph are often suggestive but not conclusive for the diagnosis of TOF. </p><p>Other advanced imaging modalities (eg, high-resolution computed tomography [CT], cardiac magnetic resonance imaging [MRI]) are sometimes used to provide additional anatomic information related to pulmonary artery anatomy, coronary artery anatomy, and the presence of aorticopulmonary collateral vessels. Cardiac catheterization is sometimes needed to further delineate anatomy and hemodynamic changes.</p><p class="headingAnchor" id="H2053956"><span class="h2">Echocardiography</span><span class="headingEndMark"> — </span>Two-dimensional echocardiography and Doppler examination allow assessment of all essential features of TOF and play a crucial role in diagnosis and preoperative evaluation. Complete echocardiographic evaluation may obviate the need for other imaging or diagnostic studies before surgical repair. Most of the information can be achieved with transthoracic echocardiography, but, occasionally, transesophageal echocardiography may be helpful for specific questions raised with transthoracic echocardiography. A complete study must address:</p><p class="bulletIndent1"><span class="glyph">●</span>Location and number of ventricular septal defects (VSDs)</p><p class="bulletIndent1"><span class="glyph">●</span>Anatomy and severity of RVOT obstruction</p><p class="bulletIndent1"><span class="glyph">●</span>Coronary artery and aortic arch anatomy</p><p class="bulletIndent1"><span class="glyph">●</span>Presence of any associated anomalies</p><p></p><p>Additional details of the echocardiographic evaluation are as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>VSD</strong> – The characteristic large, malaligned VSD must be evaluated in multiple views. The degree of aortic override can be best assessed in parasternal long-axis and apical views (<a class="graphic graphic_movie graphicRef71450" href="/z/d/graphic/71450.html" rel="external">movie 1</a> and <a class="graphic graphic_movie graphicRef79575" href="/z/d/graphic/79575.html" rel="external">movie 2</a>). The extension of the defect from the membranous septum, beneath the tricuspid valve, and into the infracristal outlet septum is well seen in the parasternal short-axis view; extension into the supracristal region, if present, can be seen in this view as well (<a class="graphic graphic_movie graphicRef73954" href="/z/d/graphic/73954.html" rel="external">movie 3</a>). Potential extension of the defect posteriorly toward the inlet septum, or apically into the trabecular septum, can be examined in apical views; the transducer is swept through serial imaging planes from the more caudal views of the inlet septum to the anteriorly angulated views, showing the overriding aorta in continuity with both the mitral and tricuspid valves.</p><p></p><p class="bulletIndent1">The subcostal views are also helpful to delineate the bounds of the VSD, allowing particularly good representation of the relationship between the defect and the tricuspid and aortic valves. The subcostal right oblique view, obtained by rotating the transducer counterclockwise from the coronal views, is also helpful in identifying any potential extension of the defect into the supracristal region. In the rare cases of restrictive VSD in this lesion, this view also defines abnormal tricuspid valve attachments [<a href="#rid36">36,37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>RVOT obstruction</strong> – The multiple levels and severity of obstruction in the RVOT can also be evaluated by echocardiography (<a class="graphic graphic_diagnosticimage graphicRef53046" href="/z/d/graphic/53046.html" rel="external">image 4</a> and <a class="graphic graphic_movie graphicRef64797" href="/z/d/graphic/64797.html" rel="external">movie 4</a>). Parasternal short-axis and subcostal coronal and sagittal views allow the best examination of the infundibulum and pulmonary valve. These views demonstrate the anterior deviation of the conal septum and the infundibular muscle bundles that contribute to infundibular obstruction. The size of the usually hypoplastic pulmonary annulus can be assessed and compared with normal values for patient size and body surface area. This is important to establish the potential need for a transannular patch. The pulmonary valve may appear thickened and may dome in these views.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary arteries</strong> – The size and anatomy of the main pulmonary artery, the pulmonary arterial confluence, and the proximal branch pulmonary arteries can also be assessed in parasternal short-axis views. The proximal branch pulmonary arteries should be assessed as far distally as possible in high parasternal views and in suprasternal notch long- and short-axis views, directing the transducer into the left and right chest (<a class="graphic graphic_movie graphicRef72460" href="/z/d/graphic/72460.html" rel="external">movie 5</a> and <a class="graphic graphic_movie graphicRef51331" href="/z/d/graphic/51331.html" rel="external">movie 6</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coronary arteries</strong> – The proximal coronary anatomy should be defined echocardiographically in patients with TOF. In addition to examining the coronary anatomy in the traditional short-axis view, the examination should include sweeping the transducer anterior to the pulmonary outflow tract in parasternal long- and short-axis views (<a class="graphic graphic_movie graphicRef63092" href="/z/d/graphic/63092.html" rel="external">movie 7</a>) [<a href="#rid38">38-40</a>]. This permits the identification of variations in coronary anatomy, including the origin of the left anterior descending from the right coronary artery or dual vessel supply to the anterior descending distribution; in these situations, coronary branches crossing anteriorly complicate the surgical approach to relief of RVOT obstruction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aortic arch</strong> – Aortic arch situs and the branching patterns of the brachiocephalic arteries are defined in the suprasternal notch long- and short-axis views. Complete evaluation of the arch in these views is also important in delineating the presence of additional potential sources of pulmonary blood flow, including aorticopulmonary collaterals and a patent ductus arteriosus (see  <a class="medical medical_review" href="/z/d/html/1421.html" rel="external">"Clinical manifestations and diagnosis of patent ductus arteriosus (PDA) in term infants, children, and adults"</a>). Dilation of the ascending aorta may be present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atrial and ventricular septa</strong> – The echocardiographic evaluation of patients with TOF is completed by using both two-dimensional imaging and color flow mapping of the atrial septum and ventricular septum in multiple imaging planes. This assessment defines additional atrial and VSDs and also evaluates potential abnormalities of pulmonary and systemic venous return and the rare associated occurrence of left-sided obstructive lesions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic echocardiographic assessment</strong> – As previously discussed, the large and generally unrestrictive defect in this lesion permits equalization of right and left ventricular pressures. The direction and degree of shunting is determined by the balance of resistance to flow into the systemic and pulmonary circulations and, to a large degree, by the severity of RVOT obstruction. The modified Bernoulli equation, applied to the peak flow velocity measured in the RVOT, can be used to calculate the outflow tract gradient:</p><p></p><div class="formulaContainer"><div class="formula"><p class="bulletIndent2">ΔP = 4V<sup>2</sup></p></div></div><p></p><p class="bulletIndent2">Where ΔP = peak pressure gradient between the RV and the pulmonary artery (mmHg), and V = velocity obtained by continuous-wave Doppler interrogation of the RVOT</p><p></p><p class="bulletIndent1">The pulmonary artery pressure can be estimated by subtracting this pressure gradient from the systemic blood pressure. (See  <a class="medical medical_review" href="/z/d/html/5315.html" rel="external">"Principles of Doppler echocardiography", section on 'Relationship between Doppler velocity and pressure gradient'</a>.)</p><p></p><p class="bulletIndent1">While the modified Bernoulli equation is not valid in the setting of tunnel-like and/or multiple levels of obstruction, values obtained with this method correlate with those obtained in the cardiac catheterization laboratory [<a href="#rid41">41</a>]. In practice, the contributions of the infundibulum value and branch pulmonary arteries cannot be separated by Doppler interrogation.</p><p></p><p class="bulletIndent1">In patients with minimal RVOT obstruction, the gradient across the RVOT will be low, the estimated pulmonary arterial pressure will be elevated, and shunting through the VSD (as assessed by pulsed Doppler and color flow mapping) will be predominantly left to right through much of the cardiac cycle. (See  <a class="medical medical_review" href="/z/d/html/5787.html" rel="external">"Isolated ventricular septal defects (VSDs) in infants and children: Anatomy, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">In patients with a large left-to-right shunt, left atrial and left ventricular dilation may be apparent by two-dimensional imaging. In patients with more severe RVOT obstruction, the estimated pulmonary artery pressure is normal and pulsed Doppler and color flow mapping demonstrate increasing right-to-left shunting at the VSD during the cardiac cycle.</p><p></p><p class="headingAnchor" id="H2054004"><span class="h2">Electrocardiogram</span><span class="headingEndMark"> — </span>The electrocardiogram in TOF typically shows right atrial enlargement and RV hypertrophy. Right-axis deviation, prominent R waves anteriorly and S waves posteriorly, an upright (<a class="graphic graphic_waveform graphicRef81339" href="/z/d/graphic/81339.html" rel="external">waveform 1</a>) T wave in V1 (after two days of life), and a qR pattern in the right-sided chest leads may also be seen (<a class="graphic graphic_waveform graphicRef81339" href="/z/d/graphic/81339.html" rel="external">waveform 1</a>). (See  <a class="medical medical_review" href="/z/d/html/2123.html" rel="external">"ECG tutorial: Chamber enlargement and hypertrophy"</a>.)</p><p class="headingAnchor" id="H2054010"><span class="h2">Chest radiograph</span><span class="headingEndMark"> — </span>The classic chest radiograph of a patient with TOF demonstrates a "boot-shaped" heart with an upturned apex and a concave main pulmonary artery segment (<a class="graphic graphic_diagnosticimage graphicRef78997" href="/z/d/graphic/78997.html" rel="external">image 5</a>). The heart size is often normal, and pulmonary flow will appear normal or decreased. A right aortic arch can be seen in 25 percent of patients.</p><p class="headingAnchor" id="H2054016"><span class="h2">Cardiac catheterization</span><span class="headingEndMark"> — </span>Although echocardiography can reveal the anatomy in many patients with TOF, cardiac catheterization may still be necessary to further delineate the anatomy. It is particularly helpful for assessing levels of RVOT obstruction, branch pulmonary artery stenosis or hypoplasia, coronary artery anatomy, presence of aorticopulmonary collaterals, and presence of accessory VSDs.</p><p>The hemodynamic findings at catheterization typically reveal normal or only mildly elevated filling pressures. The left and RV systolic pressures are equal and systemic due to the presence of the large VSD. Pulmonary artery pressures are normal or low. Saturations will indicate the degree of right-to-left shunting.</p><p>Angiographic assessment should be geared toward the information that is needed; biplane angiography is ideal. An RV injection will often adequately demonstrate the multiple levels of RV obstruction as well as the anatomy of the branch pulmonary arteries (<a class="graphic graphic_diagnosticimage graphicRef57537" href="/z/d/graphic/57537.html" rel="external">image 2</a>). This is typically done with the anteroposterior camera angled in a cranial and left anterior oblique projection, which allows better delineation of the branch pulmonary arteries. The lateral camera is kept in straight lateral projection, which provides excellent visualization of the infundibular and pulmonary valve anatomy (<a class="graphic graphic_diagnosticimage graphicRef79323" href="/z/d/graphic/79323.html" rel="external">image 6</a>).</p><p>An aortic root injection will usually provide adequate identification of the coronary arteries, although selective injections may occasionally be needed. The coronary arteries usually are seen well with the anteroposterior camera in a right anterior oblique projection and the lateral camera in a long-axial oblique projection (70LAO/20Cranial). The arch and descending aorta may also be seen in this view and provide evidence of the presence of a patent ductus arteriosus or collateral vessels. If collateral vessels are identified, selective injections are helpful to assess the areas of the pulmonary bed that they supply and whether they are the sole supply to these areas. Embolization of collaterals can be considered if they supply flow to regions that are also supplied by the native pulmonary arteries.</p><p>The VSD is best seen from a left ventricular injection in a long-axial oblique projection (<a class="graphic graphic_diagnosticimage graphicRef52641" href="/z/d/graphic/52641.html" rel="external">image 1</a>). With the anteroposterior camera in an right anterior oblique projection, one will often also see the infundibular obstruction from left-to-right flow across the VSD (<a class="graphic graphic_diagnosticimage graphicRef63257" href="/z/d/graphic/63257.html" rel="external">image 7</a>).</p><p>Cardiac catheterization can also play a therapeutic role in some patients with TOF. Balloon valvuloplasty of the pulmonary valve can improve pulmonary flow in many children; there may also be an increase in pulmonary valve annulus size that may decrease the need for transannular patch repair [<a href="#rid42">42,43</a>]. Stent implantation in the RVOT or the patent ductus arteriosus have also been used in the perinatal period to augment pulmonary flow and allow complete repair to be deferred to a later age and larger size. This is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome", section on 'Palliative intervention'</a>.)</p><p class="headingAnchor" id="H4170640973"><span class="h2">Other imaging studies</span><span class="headingEndMark"> — </span>In situations where additional anatomic information is needed beyond what echocardiography provides, CT and MRI imaging can be useful [<a href="#rid44">44</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>High-resolution CT – With improving technology, high-resolution CT scans can be performed with low radiation exposure and often without anesthesia even in infants, providing excellent intracardiac and extracardiac anatomic detail. This can be useful when evaluating branch pulmonary artery anatomy and collateral vessel distribution. Three-dimensional reconstruction provides detailed appreciation of spatial resolution.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac MRI – Cardiac MRI provides additional anatomic detail and volumetric and hemodynamic measurements that can be useful in clinical decision-making. Anesthesia is typically required for cardiac MRI in patients under seven years of age.</p><p></p><p class="headingAnchor" id="H1298646051"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/115414.html" rel="external">"Society guideline links: Congenital heart disease in infants and children"</a>.)</p><p class="headingAnchor" id="H2054022"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/83995.html" rel="external">"Patient education: Tetralogy of Fallot (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2054028"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomy</strong> – Tetralogy of Fallot (TOF) is a form of cyanotic congenital heart disease (CHD) that encompasses four anatomic features (<a class="graphic graphic_figure graphicRef82493" href="/z/d/graphic/82493.html" rel="external">figure 1</a>) (see <a class="local">'Anatomy'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Right ventricular (RV) hypertrophy</p><p class="bulletIndent2"><span class="glyph">•</span>Ventricular septal defect (VSD)</p><p class="bulletIndent2"><span class="glyph">•</span>Overriding aorta</p><p class="bulletIndent2"><span class="glyph">•</span>RV outflow tract (RVOT) obstruction</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong> – The prevalence of TOF is approximately 4 per 10,000 live births. TOF accounts for 7 to 10 percent of all CHD. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Association with genetic disorders and other CHD defects</strong> – Although TOF typically occurs sporadically without other anomalies, it can be present as part of a known syndrome or genetic disorder, such as Down, Alagille, or DiGeorge (22q11 deletion) syndromes. Other associated cardiac anomalies occur in approximately 40 percent of patients with TOF. (See <a class="local">'Genetic factors'</a> above and <a class="local">'Associated cardiac features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology</strong> – The pathophysiology of TOF largely depends upon the degree of RVOT obstruction. The direction of blood flow across the VSD is determined by the relative resistance to flow into the pulmonary and systemic circulations, and not by the size of the VSD. If the resistance to the RV outflow is lower than systemic resistance, then there is a predominant left-to-right flow and the patient is not cyanotic. However, with significant RVOT obstruction, there will be a right-to-left shunt across the VSD, resulting in cyanosis (<a class="graphic graphic_figure graphicRef82493" href="/z/d/graphic/82493.html" rel="external">figure 1</a>). (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Many infants with TOF are diagnosed prenatally. For those who present postnatally, the clinical presentation depends upon the degree of RVOT obstruction, which determines whether there is a left-to-right (acyanotic) or right-to-left (cyanotic) shunt. In general, the earlier the onset of systemic hypoxemia, the more likely it is that severe RVOT obstruction is present. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypercyanotic ("tet") spells</strong> – Patients with TOF may intermittently experience hypercyanotic ("tet") spells, in which there can be transient near occlusion of the RVOT with profound cyanosis. Tet spells typically arise when the infant becomes agitated or upset. They are characterized by hyperpnea (rapid and deep respirations), irritability, inconsolability, and progressively severe cyanosis. Prolonged spells can lead to loss of consciousness and cardiac arrest. Thus, prompt intervention is warranted. (See <a class="local">'Tet spells'</a> above and  <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome", section on 'Tet spells'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination findings</strong> – Typical findings on cardiac auscultation in patients with TOF include a crescendo-decrescendo harsh systolic ejection murmur and a single second heart sound. (See <a class="local">'Cardiac auscultation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG and chest radiograph findings</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>ECG</strong> – The ECG typically shows right atrial enlargement and RV hypertrophy (<a class="graphic graphic_waveform graphicRef81339" href="/z/d/graphic/81339.html" rel="external">waveform 1</a>). (See <a class="local">'Electrocardiogram'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chest radiograph</strong> – The classic chest radiograph of a patient with TOF demonstrates a "boot-shaped" heart with an upturned apex and a concave main pulmonary artery segment (<a class="graphic graphic_diagnosticimage graphicRef78997" href="/z/d/graphic/78997.html" rel="external">image 5</a>). The heart size is often normal, and pulmonary flow will appear normal or decreased. (See <a class="local">'Chest radiograph'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of TOF is typically made by echocardiography, which can usually delineate the location and number of VSDs (<a class="graphic graphic_movie graphicRef71450" href="/z/d/graphic/71450.html" rel="external">movie 1</a> and <a class="graphic graphic_movie graphicRef79575" href="/z/d/graphic/79575.html" rel="external">movie 2</a> and <a class="graphic graphic_movie graphicRef73954" href="/z/d/graphic/73954.html" rel="external">movie 3</a>), anatomy and severity of RVOT obstruction (<a class="graphic graphic_movie graphicRef64797" href="/z/d/graphic/64797.html" rel="external">movie 4</a> and <a class="graphic graphic_movie graphicRef72460" href="/z/d/graphic/72460.html" rel="external">movie 5</a> and <a class="graphic graphic_movie graphicRef51331" href="/z/d/graphic/51331.html" rel="external">movie 6</a>), coronary artery and aortic arch anatomy (<a class="graphic graphic_movie graphicRef63092" href="/z/d/graphic/63092.html" rel="external">movie 7</a>), presence of any associated anomalies, and hemodynamic abnormalities associated with the anatomical defects. (See <a class="local">'Echocardiography'</a> above.)</p><p></p><p class="headingAnchor" id="H28779019"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Thomas Graham Jr, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2006; 54:1301.</a></li><li><a class="nounderline abstract_t">Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153:807.</a></li><li><a class="nounderline abstract_t">Report of the New England Regional Infant Cardiac Program. Pediatrics 1980; 65:375.</a></li><li class="breakAll">Perloff JK. The Clinical Recognition of Congenital Heart Disease, 4th ed, WB Saunders, Philadelphia 1994.</li><li class="breakAll">Breitbart, RE, Fyler, DC. Tetralogy of Fallot. In: Nadas' pediatric cardiology, 2nd Ed, Keane JF, Lock JE, Fyler DC (Eds), Saunders, Philadelphia 2006. p.559.</li><li><a class="nounderline abstract_t">Dabizzi RP, Caprioli G, Aiazzi L, et al. Distribution and anomalies of coronary arteries in tetralogy of fallot. Circulation 1980; 61:95.</a></li><li><a class="nounderline abstract_t">Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of fallot. Circulation 2001; 104:2565.</a></li><li><a class="nounderline abstract_t">Greenway SC, Pereira AC, Lin JC, et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009; 41:931.</a></li><li><a class="nounderline abstract_t">Di Felice V, Zummo G. Tetralogy of fallot as a model to study cardiac progenitor cell migration and differentiation during heart development. Trends Cardiovasc Med 2009; 19:130.</a></li><li><a class="nounderline abstract_t">Griffin HR, Töpf A, Glen E, et al. Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart 2010; 96:1651.</a></li><li><a class="nounderline abstract_t">Rauch R, Hofbeck M, Zweier C, et al. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. J Med Genet 2010; 47:321.</a></li><li><a class="nounderline abstract_t">Wei D, Bao H, Liu XY, et al. GATA5 loss-of-function mutations underlie tetralogy of fallot. Int J Med Sci 2013; 10:34.</a></li><li><a class="nounderline abstract_t">Marinho C, Alho I, Guerra A, et al. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol 2009; 28:809.</a></li><li><a class="nounderline abstract_t">Kramer HH, Majewski F, Trampisch HJ, et al. Malformation patterns in children with congenital heart disease. Am J Dis Child 1987; 141:789.</a></li><li><a class="nounderline abstract_t">Freeman SB, Taft LF, Dooley KJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998; 80:213.</a></li><li><a class="nounderline abstract_t">Krantz ID, Smith R, Colliton RP, et al. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet 1999; 84:56.</a></li><li><a class="nounderline abstract_t">Takahashi K, Kido S, Hoshino K, et al. Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study. Eur J Pediatr 1995; 154:878.</a></li><li><a class="nounderline abstract_t">Webber SA, Hatchwell E, Barber JC, et al. Importance of microdeletions of chromosomal region 22q11 as a cause of selected malformations of the ventricular outflow tracts and aortic arch: a three-year prospective study. J Pediatr 1996; 129:26.</a></li><li><a class="nounderline abstract_t">Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998; 32:492.</a></li><li><a class="nounderline abstract_t">Lammer EJ, Chak JS, Iovannisci DM, et al. Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol 2009; 85:30.</a></li><li><a class="nounderline abstract_t">Bauer RC, Laney AO, Smith R, et al. Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat 2010; 31:594.</a></li><li><a class="nounderline abstract_t">Kessler-Icekson G, Birk E, Weintraub AY, et al. Association of tetralogy of Fallot with a distinct region of del22q11.2. Am J Med Genet 2002; 107:294.</a></li><li><a class="nounderline abstract_t">Bristow JD, Bernstein HS. Counseling families with chromosome 22q11 deletions: the catch in CATCH-22. J Am Coll Cardiol 1998; 32:499.</a></li><li><a class="nounderline abstract_t">van Engelen K, Topf A, Keavney BD, et al. 22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia. Heart 2010; 96:621.</a></li><li><a class="nounderline abstract_t">Kothari SS. Mechanism of cyanotic spells in tetralogy of Fallot--the missing link? Int J Cardiol 1992; 37:1.</a></li><li class="breakAll">Duff DF, McNamara DG. History and physical examination of the cardiovascular system. In: The science and practice of pediatric cardiology, Garson A Jr, Bricker TM, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.693.</li><li><a class="nounderline abstract_t">Bhat AH, Kehl DW, Tacy TA, et al. Diagnosis of tetralogy of Fallot and its variants in the late first and early second trimester: details of initial assessment and comparison with later fetal diagnosis. Echocardiography 2013; 30:81.</a></li><li><a class="nounderline abstract_t">Pepas LP, Savis A, Jones A, et al. An echocardiographic study of tetralogy of Fallot in the fetus and infant. Cardiol Young 2003; 13:240.</a></li><li><a class="nounderline abstract_t">Monaco M, Williams I. Tetralogy of Fallot: fetal diagnosis to surgical correction. Minerva Pediatr 2012; 64:461.</a></li><li><a class="nounderline abstract_t">Quartermain MD, Glatz AC, Goldberg DJ, et al. Pulmonary outflow tract obstruction in fetuses with complex congenital heart disease: predicting the need for neonatal intervention. Ultrasound Obstet Gynecol 2013; 41:47.</a></li><li><a class="nounderline abstract_t">Friedman K, Balasubramanian S, Tworetzky W. Midgestation fetal pulmonary annulus size is predictive of outcome in tetralogy of fallot. Congenit Heart Dis 2014; 9:187.</a></li><li><a class="nounderline abstract_t">Arya B, Levasseur SM, Woldu K, et al. Fetal echocardiographic measurements and the need for neonatal surgical intervention in Tetralogy of Fallot. Pediatr Cardiol 2014; 35:810.</a></li><li><a class="nounderline abstract_t">Arunamata A, Balasubramanian S, Punn R, et al. Impact of Fetal Somatic Growth on Pulmonary Valve Annulus Z-Scores During Gestation and Through Birth in Patients with Tetralogy of Fallot. Pediatr Cardiol 2018; 39:1181.</a></li><li><a class="nounderline abstract_t">Kwon EN, Parness IA, Srivastava S, et al. Subpulmonary stenosis assessed in midtrimester fetuses with tetralogy of Fallot: a novel method for predicting postnatal clinical outcome. Pediatr Cardiol 2013; 34:1314.</a></li><li><a class="nounderline abstract_t">Escribano D, Herraiz I, Granados M, et al. Tetralogy of Fallot: prediction of outcome in the mid-second trimester of pregnancy. Prenat Diagn 2011; 31:1126.</a></li><li><a class="nounderline abstract_t">Flanagan MF, Foran RB, Van Praagh R, et al. Tetralogy of Fallot with obstruction of the ventricular septal defect: spectrum of echocardiographic findings. J Am Coll Cardiol 1988; 11:386.</a></li><li><a class="nounderline abstract_t">Musewe NN, Smallhorn JF, Moes CA, et al. Echocardiographic evaluation of obstructive mechanism of tetralogy of Fallot with restrictive ventricular septal defect. Am J Cardiol 1988; 61:664.</a></li><li><a class="nounderline abstract_t">Berry JM Jr, Einzig S, Krabill KA, Bass JL. Evaluation of coronary artery anatomy in patients with tetralogy of Fallot by two-dimensional echocardiography. Circulation 1988; 78:149.</a></li><li><a class="nounderline abstract_t">Caldwell RL, Ensing GJ. Coronary artery abnormalities in children. J Am Soc Echocardiogr 1989; 2:259.</a></li><li><a class="nounderline abstract_t">Jureidini SB, Appleton RS, Nouri S. Detection of coronary artery abnormalities in tetralogy of Fallot by two-dimensional echocardiography. J Am Coll Cardiol 1989; 14:960.</a></li><li><a class="nounderline abstract_t">Houston AB, Simpson IA, Sheldon CD, et al. Doppler ultrasound in the estimation of the severity of pulmonary infundibular stenosis in infants and children. Br Heart J 1986; 55:381.</a></li><li><a class="nounderline abstract_t">Sreeram N, Saleem M, Jackson M, et al. Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol 1991; 18:159.</a></li><li><a class="nounderline abstract_t">Massoud I, Imam A, Mabrouk A, et al. Palliative balloon valvoplasty of the pulmonary valve in tetralogy of Fallot. Cardiol Young 1999; 9:24.</a></li><li><a class="nounderline abstract_t">Lapierre C, Dubois J, Rypens F, et al. Tetralogy of Fallot: Preoperative assessment with MR and CT imaging. Diagn Interv Imaging 2016; 97:531.</a></li></ol></div><div id="topicVersionRevision">Topic 5769 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16397457" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18657826" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7355042" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Report of the New England Regional Infant Cardiac Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7355042" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Report of the New England Regional Infant Cardiac Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7355042" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Report of the New England Regional Infant Cardiac Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7349946" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Distribution and anomalies of coronary arteries in tetralogy of fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11714651" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : NKX2.5 mutations in patients with tetralogy of fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19597493" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19818949" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Tetralogy of fallot as a model to study cardiac progenitor cell migration and differentiation during heart development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20937753" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19948535" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23289003" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : GATA5 loss-of-function mutations underlie tetralogy of fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19894660" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3591771" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Malformation patterns in children with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9843040" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Population-based study of congenital heart defects in Down syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10213047" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Jagged1 mutations in patients ascertained with isolated congenital heart defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8582397" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8757559" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Importance of microdeletions of chromosomal region 22q11 as a cause of selected malformations of the ventricular outflow tracts and aortic arch: a three-year prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9708481" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Frequency of 22q11 deletions in patients with conotruncal defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19067405" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Chromosomal abnormalities among children born with conotruncal cardiac defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20437614" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11840485" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Association of tetralogy of Fallot with a distinct region of del22q11.2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9708482" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Counseling families with chromosome 22q11 deletions: the catch in CATCH-22.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20357389" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : 22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1428277" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Mechanism of cyanotic spells in tetralogy of Fallot--the missing link?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1428277" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Mechanism of cyanotic spells in tetralogy of Fallot--the missing link?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22963380" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Diagnosis of tetralogy of Fallot and its variants in the late first and early second trimester: details of initial assessment and comparison with later fetal diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12903870" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : An echocardiographic study of tetralogy of Fallot in the fetus and infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22992529" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Tetralogy of Fallot: fetal diagnosis to surgical correction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22605656" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pulmonary outflow tract obstruction in fetuses with complex congenital heart disease: predicting the need for neonatal intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23834770" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Midgestation fetal pulmonary annulus size is predictive of outcome in tetralogy of fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24352665" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Fetal echocardiographic measurements and the need for neonatal surgical intervention in Tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29632959" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Impact of Fetal Somatic Growth on Pulmonary Valve Annulus Z-Scores During Gestation and Through Birth in Patients with Tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23389098" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Subpulmonary stenosis assessed in midtrimester fetuses with tetralogy of Fallot: a novel method for predicting postnatal clinical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21928295" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Tetralogy of Fallot: prediction of outcome in the mid-second trimester of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3339179" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Tetralogy of Fallot with obstruction of the ventricular septal defect: spectrum of echocardiographic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3344699" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Echocardiographic evaluation of obstructive mechanism of tetralogy of Fallot with restrictive ventricular septal defect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3383399" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Evaluation of coronary artery anatomy in patients with tetralogy of Fallot by two-dimensional echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2697306" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Coronary artery abnormalities in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2794284" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Detection of coronary artery abnormalities in tetralogy of Fallot by two-dimensional echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3964506" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Doppler ultrasound in the estimation of the severity of pulmonary infundibular stenosis in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1711062" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10323535" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Palliative balloon valvoplasty of the pulmonary valve in tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26969119" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Tetralogy of Fallot: Preoperative assessment with MR and CT imaging.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
